BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6262604)

  • 1. A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy.
    Luisi M; Franchi F; Kicovic PM
    Maturitas; 1980 Dec; 2(4):311-9. PubMed ID: 6262604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol.
    Haspels AA; Luisi M; Kicovic PM
    Maturitas; 1981 Dec; 3(3-4):321-7. PubMed ID: 6801440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.
    Kicovic PM; Cortes-Prieto J; Milojević S; Haspels AA; Aljinovic A
    Maturitas; 1980 Dec; 2(4):275-82. PubMed ID: 6785553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of estradiol vaginal cream in postmenopausal women.
    Dickerson J; Bressler R; Christian CD; Hermann HW
    Clin Pharmacol Ther; 1979 Oct; 26(4):502-7. PubMed ID: 226306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    Englund DE; Johansson ED
    Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, open, controlled trial to evaluate the efficacy of Honglilai Vaginal Cream and Premarin Vaginal Cream for Genitourinary Syndrome of Menopause in different subgroups of Chinese postmenopausal women.
    Yang M; Lin S; Zheng S; Sun A; Bian M; Li S; Liu J; Hu L; Hui N; Zhong J; Hou H; Yue T; Gao X; Bai W
    Gynecol Endocrinol; 2022 Oct; 38(10):861-867. PubMed ID: 36067791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovestin cream in the treatment of postmenopausal vulvovaginal atrophy and atrophic vaginitis].
    Grcić R; Stavrić V; Knezević A; Kadija D; Perisić Z
    Med Pregl; 1987; 40(1-2):65-72. PubMed ID: 3657725
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravaginal administration of conjugated estrogens in premenopausal and postmenopausal women.
    Furuhjelm M; Karlgren E; Carlström K
    Int J Gynaecol Obstet; 1980; 17(4):335-9. PubMed ID: 6102051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
    J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
    Englund DE; Victor A; Johansson ED
    Maturitas; 1981 Aug; 3(2):125-33. PubMed ID: 6793811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
    Fåhraeus L; Larsson-Cohn U
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia.
    Volpe A; Botticelli A; Abrate M; Dalla Vecchia E; Mantovani M; Carani C; Grasso A; Mazza V; Di Renzo GC
    Maturitas; 1982 Apr; 4(1):73-9. PubMed ID: 6285154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.